ACS 2012
Recent articles
Mutations in both gene copies more common in autism
People with autism are twice as likely as controls to have mutations that disable both copies of a gene, according to preliminary research presented Wednesday at the Autism Consortium Research Symposium in Boston.
Mutations in both gene copies more common in autism
People with autism are twice as likely as controls to have mutations that disable both copies of a gene, according to preliminary research presented Wednesday at the Autism Consortium Research Symposium in Boston.
Autism Speaks launches scheme to develop drugs, devices
The research and advocacy organization Autism Speaks plans to launch a nonprofit arm that will fund companies to develop treatments for the disorder, Robert Ring, head of translational research for the organization, announced yesterday at the Autism Consortium Research Symposium in Boston.
Autism Speaks launches scheme to develop drugs, devices
The research and advocacy organization Autism Speaks plans to launch a nonprofit arm that will fund companies to develop treatments for the disorder, Robert Ring, head of translational research for the organization, announced yesterday at the Autism Consortium Research Symposium in Boston.
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”